The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019

The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination. Simplified, shorter and preferably less toxic drug regimens are being investigated for pulmonary TB to counteract emergence of drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pranger, A. D., van der Werf, T. S., Kosterink, J. G. W., Alffenaar, J. W. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373389/
https://www.ncbi.nlm.nih.gov/pubmed/30617959
http://dx.doi.org/10.1007/s40265-018-1043-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373389/
https://www.ncbi.nlm.nih.gov/pubmed/30617959
http://dx.doi.org/10.1007/s40265-018-1043-y

Ejemplares similares